Luiza Spiru

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser, Frans R.J. Verhey, Dirk L. Knol et al. · The Lancet Neurology · 2009 · 621 citations

Medicine, Neurology, Neuroscience +16

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

Willemijn J. Jansen, Rik Ossenkoppele, Betty M. Tijms et al. · JAMA Psychiatry · 2017 · 148 citations · Full text

Medicine, Neurology, Neuroscience +17

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Ingrid S. van Maurik, Stephanie J. B. Vos, Isabelle Bos et al. · The Lancet Neurology · 2019 · 145 citations · Full text

Medicine, Neurology, Neuroscience +15

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment

Inez H.G.B. Ramakers, Frans R.J. Verhey, Philip Scheltens et al. · Psychological Medicine · 2012 · 118 citations

Medicine, Neurology, Neuroscience +17

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz et al. · Alzheimer s Research & Therapy · 2023 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17